Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-614-2013

Drug recall · July 3, 2013

5% Dextrose Injection USP recall

Why: Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

5% Dextrose Injection USP, a) 250 mL (NDC 0409-7922-02), b) 500 mL (NDC 0409-7922-30), by Hospira, Inc., Lake Forest, IL 60045

Lots / codes

Lot #: a) 01-201-JT, Exp 7/12; b) Lot 91-054-JT, Exp 7/12

Quantity
267,288 units
Company
Hospira Inc., Lake Forest, IL
Distribution
Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia
Initiated
May 4, 2012 · Voluntary: Firm initiated
Classified
June 21, 2013
Reported
July 3, 2013
Ended
July 17, 2015
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.